Market
Resmed sharpens sleep care focus with $490m software business sale
ResMed sold MatrixCare, its software business, to private-equity firm Frazier Healthcare Partners for $490 million, less than a decade after acquiring it for $750 million. The divestment reflects ResMed's strategic pivot to concentrate on its core sleep and respiratory care device portfolio.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network